✦ LIBER ✦

A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer

✍ Scribed by Dittrich, Christian; Papai-Szekely, Zsolt; Vinolas, Nuria; Sederholm, Christer; Hartmann, Joerg T.; Behringer, Dirk; Kazeem, Gbenga; Desaiah, Durisala; Leschinger, Monika I.; von Pawel, Joachim

Book ID: 122768197
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 517 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-arm randomised controlled phase 2

Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer

✍ Lee, Dae Ho; Lee, Jung Shin; Kim, Sang-We; Rodrigues-Pereira, José; Han, Baohui; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 872 KB

A cross-market cost comparison of erloti

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer

✍ Nuijten, Mark J.C.; de Castro Carpeño, Javier; Chouaid, Christos; Vergnenègre, A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Second-line pemetrexed versus docetaxel

Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: A randomized, open-label study

✍ Sun, Y.; Wu, Y.-L.; Zhou, C.-C.; Zhang, L.; Zhang, L.; Liu, X.-Y.; Yu, S.-Y.; Ji 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Phase II study of pemetrexed plus oxalip

Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients

✍ Dae Ho Lee, Chang-Min Choi, Sang-We Kim, Cheolwon Suh, Jung-Shin Lee 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 158 KB

Pharmacogenetic study of patients with a

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin

✍ Tiseo, Marcello; Giovannetti, Elisa; Tibaldi, Carmelo; Camerini, Andrea; Di Cost 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 285 KB

PCN43 COST COMPARISON OF ERLOTINIB VERSU

PCN43 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN ITALY

✍ S Ravera; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB